Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-09

Clinical Trial Update: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating systemic oxaliplatin or intra-arterial chemotherapy with leucovorin-5-fluorouracil, with or without irinotecan, in combination wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Camptosar (irinotecan)
  • Eloxatin (oxaliplatin)
  • Leucovorin (folinic acid)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Colorectal Neoplasms | Phase 3 | Status: RECRUITING